Human melanoma antigen AH is an autoantigenic ganglioside related to GD2.
Open Access
- 1 December 1982
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 156 (6), 1884-1889
- https://doi.org/10.1084/jem.156.6.1884
Abstract
AH antigen, initially defined by an antibody present in a melanoma patient, is a cell surface antigen found on approximately 65% of melanoma cell lines. Absorption analysis indicates that AH is a differentiation antigen marking normal and malignant cells of neuroectodermal origin. The AH determinant has been found to be related to GD2 ganglioside.Keywords
This publication has 19 references indexed in Scilit:
- REACTION OF ANTIBODIES THAT CAUSE PAROXYSMAL COLD HEMOGLOBINURIA (PCH) WITH GLOBOSIDE AND FORSSMAN GLYCOSPHINGOLIPIDS1979
- High-performance thin-layer chromatography and densitometric determination of brain ganglioside compositions of several speciesAnalytical Biochemistry, 1978
- Serological Identification of the New Cold Agglutinin Specificity Anti-GdVox Sanguinis, 1977
- A Waldenström macroglobulin that is both a cold agglutinin and a cryoglobulin because it binds N -acetylneuraminosyl residuesProceedings of the National Academy of Sciences of the United States of America, 1977
- Isolation and characterization of a novel trisialoganglioside, GT1a, from human brain.Journal of Biological Chemistry, 1977
- Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.The Journal of Experimental Medicine, 1976
- A human cold agglutinin which binds lacto-N-neotetraose.1976
- Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.Proceedings of the National Academy of Sciences of the United States of America, 1976
- Anti‐Pr3: Serological and Immunochemical Identification of a New Anti‐Pr SubspecificityVox Sanguinis, 1976
- IMMUNOCHEMICAL STUDIES ON BLOOD GROUPSThe Journal of Experimental Medicine, 1972